These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 36958424)
1. Targeting autophagy receptors OPTN and SQSTM1 as a novel therapeutic strategy for osteoporosis complicated with Alzheimer's disease. Duan R; Hong CG; Chen ML; Wang X; Pang ZL; Xie H; Liu ZZ Chem Biol Interact; 2023 May; 377():110462. PubMed ID: 36958424 [TBL] [Abstract][Full Text] [Related]
2. The cargo receptor SQSTM1 ameliorates neurofibrillary tangle pathology and spreading through selective targeting of pathological MAPT (microtubule associated protein tau). Xu Y; Zhang S; Zheng H Autophagy; 2019 Apr; 15(4):583-598. PubMed ID: 30290707 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of miR-331-3p and miR-9-5p ameliorates Alzheimer's disease by enhancing autophagy. Chen ML; Hong CG; Yue T; Li HM; Duan R; Hu WB; Cao J; Wang ZX; Chen CY; Hu XK; Wu B; Liu HM; Tan YJ; Liu JH; Luo ZW; Zhang Y; Rao SS; Luo MJ; Yin H; Wang YY; Xia K; Tang SY; Xie H; Liu ZZ Theranostics; 2021; 11(5):2395-2409. PubMed ID: 33500732 [TBL] [Abstract][Full Text] [Related]
4. Autophagy receptor OPTN (optineurin) regulates mesenchymal stem cell fate and bone-fat balance during aging by clearing FABP3. Liu ZZ; Hong CG; Hu WB; Chen ML; Duan R; Li HM; Yue T; Cao J; Wang ZX; Chen CY; Hu XK; Wu B; Liu HM; Tan YJ; Liu JH; Luo ZW; Zhang Y; Rao SS; Luo MJ; Yin H; Wang YY; Xia K; Xu L; Tang SY; Hu RG; Xie H Autophagy; 2021 Oct; 17(10):2766-2782. PubMed ID: 33143524 [TBL] [Abstract][Full Text] [Related]
5. Autophagy in microglia degrades extracellular β-amyloid fibrils and regulates the NLRP3 inflammasome. Cho MH; Cho K; Kang HJ; Jeon EY; Kim HS; Kwon HJ; Kim HM; Kim DH; Yoon SY Autophagy; 2014 Oct; 10(10):1761-75. PubMed ID: 25126727 [TBL] [Abstract][Full Text] [Related]
6. Cholesterol alters mitophagy by impairing optineurin recruitment and lysosomal clearance in Alzheimer's disease. Roca-Agujetas V; Barbero-Camps E; de Dios C; Podlesniy P; Abadin X; Morales A; Marí M; Trullàs R; Colell A Mol Neurodegener; 2021 Mar; 16(1):15. PubMed ID: 33685483 [TBL] [Abstract][Full Text] [Related]
7. The ICP0 Protein of Herpes Simplex Virus 1 (HSV-1) Downregulates Major Autophagy Adaptor Proteins Sequestosome 1 and Optineurin during the Early Stages of HSV-1 Infection. Waisner H; Kalamvoki M J Virol; 2019 Nov; 93(21):. PubMed ID: 31375597 [TBL] [Abstract][Full Text] [Related]
8. Temsirolimus promotes autophagic clearance of amyloid-β and provides protective effects in cellular and animal models of Alzheimer's disease. Jiang T; Yu JT; Zhu XC; Tan MS; Wang HF; Cao L; Zhang QQ; Shi JQ; Gao L; Qin H; Zhang YD; Tan L Pharmacol Res; 2014 Mar; 81():54-63. PubMed ID: 24602800 [TBL] [Abstract][Full Text] [Related]
9. Co-Localization of Glia Maturation Factor with NLRP3 Inflammasome and Autophagosome Markers in Human Alzheimer's Disease Brain. Ahmed ME; Iyer S; Thangavel R; Kempuraj D; Selvakumar GP; Raikwar SP; Zaheer S; Zaheer A J Alzheimers Dis; 2017; 60(3):1143-1160. PubMed ID: 28984607 [TBL] [Abstract][Full Text] [Related]
10. Clozapine Improves Memory Impairment and Reduces Aβ Level in the Tg-APPswe/PS1dE9 Mouse Model of Alzheimer's Disease. Choi Y; Jeong HJ; Liu QF; Oh ST; Koo BS; Kim Y; Chung IW; Kim YS; Jeon S Mol Neurobiol; 2017 Jan; 54(1):450-460. PubMed ID: 26742522 [TBL] [Abstract][Full Text] [Related]
11. Expression Profiling of Cytokine, Cholinergic Markers, and Amyloid-β Deposition in the APPSWE/PS1dE9 Mouse Model of Alzheimer's Disease Pathology. Reale M; D'Angelo C; Costantini E; Di Nicola M; Yarla NS; Kamal MA; Salvador N; Perry G J Alzheimers Dis; 2018; 62(1):467-476. PubMed ID: 29439355 [TBL] [Abstract][Full Text] [Related]
12. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease. Zhang W; Hao J; Liu R; Zhang Z; Lei G; Su C; Miao J; Li Z Behav Brain Res; 2011 Sep; 222(2):342-50. PubMed ID: 21513747 [TBL] [Abstract][Full Text] [Related]
13. Intermittent hypoxia treatment alleviates memory impairment in the 6-month-old APPswe/PS1dE9 mice and reduces amyloid beta accumulation and inflammation in the brain. Yue X; Zhou Y; Qiao M; Zhao X; Huang X; Zhao T; Cheng X; Fan M; Zhao Y; Chen R; Zhu L Alzheimers Res Ther; 2021 Nov; 13(1):194. PubMed ID: 34844651 [TBL] [Abstract][Full Text] [Related]
14. Ganoderic Acid A Promotes Amyloid-β Clearance (In Vitro) and Ameliorates Cognitive Deficiency in Alzheimer's Disease (Mouse Model) through Autophagy Induced by Activating Axl. Qi LF; Liu S; Liu YC; Li P; Xu X Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34074054 [TBL] [Abstract][Full Text] [Related]
15. Progressive Spatial Memory Impairment, Brain Amyloid Deposition and Changes in Serum Amyloid Levels as a Function of Age in APPswe/PS1dE9 Mice. Fu L; Sun Y; Guo Y; Yu B; Zhang H; Wu J; Yu X; Wu H; Kong W Curr Alzheimer Res; 2018; 15(11):1053-1061. PubMed ID: 29984654 [TBL] [Abstract][Full Text] [Related]